Xgeva.com

534

Daily Visitors
6 months ago

Last scanned
13 years

Domain Age
No data

Global Rank

Serious Bone Problem Prevention | XGEVA® (denosumab) Injection

Learn about XGEVA®, an injection treatment used to help prevent serious bone problems in people with multiple myeloma or bone metastases from solid tumors. See Full PI & Safety Info.

Network Data

This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for xgeva.com: 13.249.39.18, 13.249.39.47, 13.249.39.52, 13.249.39.115. Moreover, DNS used with this website include ns-1464.awsdns-55.org, ns-1539.awsdns-00.co.uk, ns-194.awsdns-24.com, ns-944.awsdns-54.net. Subnet identifier ranges from 13.249.0.0 to 13.249.255.255. Classless Inter-Domain Routing (CIDR) is 13.249.0.0/16. ARIN net type is Reallocated.

534

Daily Visitors
6 months ago

Last scanned
13 years

Domain Age
No data

Global Rank

ADDRESSING DETAILS

Hosting Company

Amazon.com, Inc.
IPs

13.249.39.18, 13.249.39.47, 13.249.39.52, 13.249.39.115
DNS

ns-1464.awsdns-55.org

ns-1539.awsdns-00.co.uk

ns-194.awsdns-24.com

ns-944.awsdns-54.net

OWNERSHIP

Created

2010-06-07
Expires

2024-06-07
Owner

Domain Administration (Amgen Inc.)
Registar

MarkMonitor Inc.
Owner Emails

amgendomains@amgen.com

The registrar of xgeva.com is MarkMonitor Inc. and the name expires on 2024-06-07. According to open source data, you can reach the owner at amgendomains@amgen.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.